News

C-Path Forms Drug Testing Pact

The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companies to share drug-testing methods in an effort to improve drug safety.

pdf

C-Path Forms Drug Testing Pact

Register Now for C-Path’s Premier Global Impact Conference

Operationalizing Hippocampal Volume as an Enrichment Biomarker for Amnestic Mild Cognitive Impairment Trials: Effect of Algorithm, Test-Retest Variability, and Cut Point on Trial Cost, Duration, and Sample Size

Nurses’ Knowledge, Communication Needs, and Future Directions in Neonatal Research